Published: April 27, 2020 at 2:35 a.m. ET A trial in a New York hospital is testing the heartburn medication Pepcid as a treatment for COVID-19, according to a report in Science. Pepcid, a generic drug marketed by Merck MRK, +0.68% and Johnson & Johnson JNJ, -0.41%, is being tested on 187 COVID-19 patients in…
Get all the latest news on coronavirus and more delivered daily to your inbox. Sign up here.A new international trial will examine whether a common anti-inflammatory drug known as colchicine could ward off COVID-19 symptoms and potentially prevent the need for hospitalization for some patients.The study, which has the University of California-San Francisco and New York…
(Oona Zenda/KFF Health News) As Grace Griffin and her husband were welcoming their long-awaited baby — a daughter — Griffin found herself worried about looming medical bills and unsure if their family could pay for the care they needed. “This whole experience has me wondering (keeping me up at night, actually): Can we ever afford
LYON, France — Halving the dose of antenatal betamethasone given to prevent severe respiratory distress syndrome (RDS) in infants does not appear to affect later intelligence quotient (IQ) scores or other measures of neurodevelopment, suggests a follow-up study of a randomized trial. However, it is unclear from the present data, presented at the Congress of
After years of searching for affordable health insurance, Trey Wright discovered Georgia Pathways to Coverage. The state’s limited Medicaid expansion program allowed the 27-year-old living in the rural city of Jesup in southeastern Georgia to finally visit a primary care doctor regularly. It also covered weekly shots to manage an array of allergies, saving him